We have examined the influence of VM26 (teniposide), a specific inhibitor of mammalian type II DNA topoisomerase, on the replication of SV40 minichromosomes in vitro. The replication system we used consists of replicative intermediate SV40 chromatin as substrate which is converted to mature SV40 chromatin in the presence of ATP, deoxynucleotides and a protein extract from uninfected cells. The addition of 100u.M VM26 to this system reduces DNA synthesis to 70 to 80 percent of the control and leads to an accumulation of 'late replicative intermediates'. The VM26 induced block of replication was not released by the addition of large quantities of type I DNA topoisomerase. We conclude, that type II DNA topoisomerase is essential for the final replication steps leading from late Cairns structures of replicative intermediates to monomeric minichromosoms. It appears that type I DNA topoisomerase can function as a swivelase during most of the replicative elongation phase, but must later be replaced by type II DNA topoisomerase.
INTRODUCTION
For the replication of its genome the Simian Virus 40 (SV40) uses host cell enzymes together with the virally coded T-antigen which functions as an initiator protein as well as a DNA helicase.
Replicating as well as mature DNA is packaged into a nucleosomal structure similar to that of the host genome. SV40 minichromosomes thus provide a model system for eukaryotic chromatin replication (for review see ref.nr. 1,2 and references therein). During chromatin replication the two intertwined parental DNA strands have to be completely unlinked to topologically independent daughter molecules. The enzymes involved in this process are topoisomerases which are classified as type I and type II enzymes according to their different biochemical properties in in vitro reactions (for review see ref.nr 3 and 4). DNA topoisomerases have been proposed to function as DNA swivelases to remove the torsional stress introduced by positive supercoiling which may occur during the replication of topologically fixed DNA molecules. This possibility was supported by studies with yeast strains mutated in the gene for either type I or type II DNA topoisomerase. Inactivation of both genes results in an immediate stop of DNA synthesis whereas either fttpj. or ioj£ mutants replicate normally (5) . This indicates that DNA topoisomerases are required continuously throughout ongoing DNA replication, probably as DNA swivelases, and that type I as well as type II DNA Nucleic Acids Research topoisomerases are able to perform this function. Furthermore, studies with yeast strains mutated in the DNA topoisomerase II gene furthermore suggested a role of the type II enzymes in the segregation of fully replicated intertwined replication products (6) . Such DNA catenaries were, under certain conditions, observed during SV40 chromatin replication in vivo (7, 8) , as well as in a cell free soluble replication system for T-antigen dependent replication of plasmid DNA bearing the SV40 origin of DNA replication. In this in vitro system SV 40 catenanes are formed provided that DNA topoisomerase II is absent or inhibited by specific drugs (9) . We have used a cell free soluble system which supports SV40 chromatin replication from in vivo initiated minichromosomes (10) to analyse the effect of VM26 (epipodophylotoxin), a specific inhibitor of eukaryotic type II DNA topoisomerase (11) . In this system SV40 molecules are faithfully replicated and the daughter molecules are separated when the two replication forks arrive at the terminus of DNA replication to give mature SV40 chromosomes. This system therefore seems to be appropriate to investigate the nature of the proposed swivelase activity during SV40 chromatin replication as well as the mechanism of segregation of daughter molecules to mature SV40 minichromosomes.
MATERIAL AND METHODS

Cells and Virus.
African Green Monkey Kidney (TC-7) cells were grown at 37°C in 145 mm diameter plastic dishes in Dulbecco's modified Eagle's medium (DME, Gibco) supplemented with 7.5% calf serum. The cells were infected at half confluency with wild type SV40 strain 777 at a multiplicity of 10 pfu/cell. The SV40 virus DNA was labeled with 50u.Ci ( 3 H)thymidine in 20ml DME from 24 to 36 hours after infection.
Cells were harvested 36 hours after infection.
Replication of SV40 nucleoprotein complexes. Viral nucleoprotein complexes were extracted from isolated nuclei into 100uJ buffer A (20mM Hepes pH 7.8; 5mM potassium acetate; 0.5mM magnesium acetate; 1mM dithiotreitol; 5mM sodium disulfite) per 145mm plate (12) . For DNA synthesis in vitro. 200u.l of the nuclear extract, equivalent to 1x10 7 nuclei, containing replicating as well as different forms of mature SV40 minichromosomes, were added to 200uJ of cytosol prepared from rapidly growing uninfected TC-7 cells (protein concentration 8 mg/ml). A fivefold concentrated reaction mixture was added to give final concentrations of 20mM Hepes pH 7.8; 45mM potassium acetate; 10mM magnesium acetate; 2mM ATP; 0.1 mM each of UTP.GTP.CTP; 0.1 mM dTTP, dGTP, dCTP; 2.5u.M ( 32 P)dATP (specific activity 10000cpm/pmol); 5mM phosphoenol pyruvate; 20 u.g/ml pyruvate kinase; 1mM dithiotreitol and 5mM sodium disulfite (13, 14) . The reaction mixtures were incubated for up to 45 min at 30°C as specified in the figure legends. DNA synthesis was terminated on ice by the addition of 20mM EDTA /100mM NaCI (final concentrations were added dissolved in identical volumes of DMSO. The incorporated radioactivity, normalized to the amount of ( 3 H) labeled SV40 DNA present, is given in percent of the control reaction performed with DMSO (A). The total incorporation after 7.5 and 30 min at 30°C is given in B.
RESULTS
Inhibition
VM26 (Table I) . It is also known that the DNA helicase activity of large T-antigen remained unchanged within the concentration range used in this study (M. Wiekowski, unpublished observation).
Analysis of replication products
Velocity gradient centrifugation and agarose gel electrophoresis under neutral or denaturing conditions were used to obtain more information about the inhibition of DNA synthesis by VM26. In these experiments, SV40 nucleoprotein complexes, uniformly labeled in vivo with (^H) thymidine, were incubated for 3 minutes at 25°C under standard reaction conditions for in vitro DNA replication with ( 32 P)dATP as the radioactively labeled nucleotide (see: Methods). One sample was immediately placed on ice to interupt in vitro replication cpulse'). A 200 fold excess of unlabeled dATP was added to a second sample and incubation was continued for 27 minutes at 30°C ("chase'). The third sample was supplemented with a 200 fold excess of unlabeled dATP and, additionally, with 100u,M VM26 before the incubation was continued for 27 minutes as in the control chase reaction. The SV40 DNA was purified from the three samples and analysed by zone velocity sedimentation. The "pulse' labeled in vitro synthesized SV40 DNA sedimented like replicating intermediate DNA as a broad peak with 27S ahead of the in vivo labeled mature SV40 DNA (Fig.3A) . During the control chase (in the absence of VM26), replicating intermediates were completely converted to mature SV40 DNA and co-sedimented with the in vivo labeled SV40 DNA molecules, which served as an internal marker in these experiments (Fig.3B) . However, when the chase reaction was performed in the presence of VM26, replicating SV40 DNA was not converted to mature fully replicated SV40 DNA. Instead, the in vitro pulse labeled SV40 DNA remained at the position of replicative intermediate DNA, sedimenting slightly faster than the monomeric SV40 DNA marker (Fig.3C) .
What is the nature of the fast sedimenting labeled DNA form that accumulated during in vitro replication in the presence of VM26 ? To address this question, we investigated the labeled DNA by agarose gel electrophoresis before and after treatment with various restriction endonucleases. As shown in Figure 4A , untreated pulse labeled nascent DNA was found to be broadly distributed, ranging from early replicating forms, migrating almost as fast as supercoiled form I DNA, to late replicating structures (lane 1). After the control chase, most of these replicating intermediates were converted to the supercoiled form I SV40 DNA (Fig4A; lane 3) . This conversion was drastically inhibited by VM26 ( Fig.4A; lane 2) . In presence of VM26, DNA structures accumulated which migrated like late replicative intermediates (22).
The labeled DNA was then restricted using enzymes which cut SV40 DNA at one single site. If the DNA forms, produced in the presence of VM26, were catenated circles we would expect, to obtain DNA molecules of unit length (form III DNA) as with restricted mature SV40 DNA (see: lanes 3 in Fig.48 and C) . However, in case of late replicating intermediates we would obtain X-shaped or O-shaped restriction products depending on the location of the restriction site relative to the growing replication fork (see: panel E, Fig.4) . These structures are known to migrate between relaxed (Fig. 4E ). DNA fragments with replication forks will migrate more slowly in neutral agarose gels than the corresponding completely replicated fragments. These structures can be seen as a diffuse distribution of radioactivity above the Pst I fragments in figure   4D . Comparison of the products labeled during the pulse reaction ( Fig.4D ; lane 1) with those after the 27 minutes chase reaction( 
Addition of purified DNA topoisomerase I
We did not observe large amounts of catenated SV40 DNA molecules when DNA topoisomerase II was inhibited by VM26. This could be due to a deficiency of DNA topoisomerase I in our in vitro replication system. However, a standard reaction mixture contained about 200 units of DNA topoisomerase I, an amount, sufficient to relax 200u.g of M13 RF DNA under the conditions of the soluble system during the 30min incubation at 30°C. Addition of up to 400 units of purified DNA topoisomerase I had no effect on the total incorporation of ( 32 P)dATP into SV40 DNA (Table I) in vitro studies. The experimental system we used, has been originally described by Su and DePamphilis (10) and successfully used before in several studies performed in this laboratory (12, 13, 14) . In this system, in vivo initiated replicating SV40 minichromosomes are converted to mature viral chromatin complexes in a reaction involving discontinuous and bidirectional semiconservative DNA replication. For the present purpose, this system is advantageous as it allows the exclusive investigation of the elongation and the termination phases of DNA replication, in contrast to more recently developed replication systems, which require an T-antigen catalyzed initiation step on histone free origin-containing DNA (26, 27, 28) .
Using this elongation system we were able to show that VM26 caused a reduction of overall DNA synthesis by 20 to 30 percent. This reduction is at least partially due to a premature halt in DNA replication, resulting in the accumulation of large amounts of incompletely replicated SV40 molecules and the formation of a minor fraction of catenated minichromosomes. Thus, our in vitro studies support a conclusion drawn previously from in vivo experiments (15) , namely, that topoisomerase II is required not only for segregation of catenated DNA molecules but also during the final elongation phase. These last steps in the SV40 replication cycle include the unwinding of the remaining terminal section of the parental DNA, concommitant with replication of the unwound DNA, and finally, the release of gapped monomeric progeny minichromosomes (29) . It is possible that two closely spaced replication forks approaching each other at the replication terminus, exclude type I DNA topoisomerase which may act as a swivelase at or ahead of replication forks. In this situation the required swivelase function may be performed by DNA topoisomerase II which could act at sites behind the replication fork on the newly replicated DNA branches. Continued DNA replication leads then to gapped monomeric circles, the products of the preferred segregation pathway (8).
We note, however, that a significant amount of replication forks in VM26 arrested replicative intermediates have not yet passed the Pst I restriction sites which are located at distances of 500 bp on both sides of the terminus (Fig.4) . Thus, topoisomerase II begins to function as an essential terminal swivelase at a point in the SV40 replication cycle when 70-80% of the molecule is replicated.
The remaining unreplicated section of replicating minichromosomes is still covered with nucleosomes (30) and could be in a compact nucleoprotein conformation that may exclude topoisomerase I as discussed above. But alternative explanations must be considered. For example, only a few molecules of topoisomerase I could be thought to be stably bound to statistically distributed sites on SV40 chromatin, thus providing the swivelase activity during DNA replication (31) . The probability of the presence of topoisomerase I on the terminal segment of replicating DNA would then be rather low, and topoisomerase II would be required as a swivelase for the final replication steps.
Experiments by others have been interpreted to mean that the major function of type II DNA topoisomerase in DNA replication is the decatenation of interlocked circles, as a major product of the replication cycle. First, Sundin and Varshavsky (7) Second, it has also been shown most recently in a soluble system, that supports replication of SV40 DNA (9) , that the inhibition of DNA topoisomerase II by VM26 or the depletion of the extracts by antibodies against DNA topoisomerase II resulted in the accumulation of catenated SV40 daughter molecules. However, in these in vitro studies, high amounts of enzymes in concentrated nuclear extract have been used to replicate SV40 DNA. These extracts, for example, contain twenty percent of the total DNA topoisomerase I (8) usually bound to cellular chromatin in the nucleus of growing cells, probably much more than is available forSV40 replication in vivo (32) . If the same is true for DNA polymerase ct/DNA primase, T-antigen helicase or other proteins, these high concentrations of replication factors may help to overcome the inhibition of DNA replication by VM26
and to uncouple termination of DNA replication from segregation of daughter molecules in vitro.
In summary, the data from our experiments in vivo as well as in vitro demonstrate, that topoisomerase II is required, most probably as a swivelase, for the replication of a terminal segment of the SV40 genome. It is quite likely that the termination of the replication cyde and the segregation
